Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat

• Autorzy: El-Sokkary G H , Kamel E.S. , Reiter R.J.
• Języki publikacji: EN

Abstrakty

EN

Oxidative stress is a likely molecular mechanism in lead neurotoxicity. Considering the antioxidant properties of melatonin, this study investigated the neuroprotective potential of melatonin in the hippocampus and corpus striatum of rats treated with lead. Three groups of male rats (control, lead acetate-treated [100 mg/kg], and lead acetate plus melatonin [10 mg/kg] for 21 consecutive days) were used. Levels of products of lipid peroxidation (LPO), glutathione (GSH) and superoxide dismutase (SOD) activity were measured in brain homogenates. Histological changes in the pyramidal cells of the hippocampus and the putamen of the corpus striatum were examined. The results documented increased LPO and decreased GSH and SOD activity in the brain homogenates of lead-treated rats. Histological observations revealed severe damage and a reduction in neuronal density in the hippocampus and corpus striatum. When melatonin was given to lead-treated rats, it almost completely attenuated the increase in LPO products and restored GSH levels and SOD activity. Also, the morphological damage was reduced and neuronal density was restored by melatonin. Considering the ease with which melatonin enters the brain, these results, along with previous observations, suggest that melatonin may be useful in combating free radical-induced neuronal injury that is a result of lead toxicity.

Słowa kluczowe

EN

melatonin; superoxide dismutase; lead acetate; corpus striatum; antioxidative property; oxidative stress; glutathione; neurotoxicity; hippocampus; lead; lipid peroxidation; rat

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2003
• Tom: 08
• Numer: 2
• Opis fizyczny: p.461-470,fig.

Twórcy

autor

El-Sokkary G H

• Assiut University, Assiut, Egypt

autor

Kamel E.S.

autor

Reiter R.J.

Bibliografia

• 1.Finkelstein, Y., Markowitz, M.E. and Rosen, J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Rev. 27 (1998) 168-176.
• 2.Gabr, M.A., El-Badry, M. and Wahdaan, M.H. A study on the effects of inorganic lead on postnatal development of the motor cerebral cortex in albino rat. Assiut Med. J. 26 (2002) 133-145.
• 3.Villeda-Hernandez, J., Barroso-Moguel, R., Mendez-Armenta, M., Nava-Ruiz, C., Huerta-Romero, R. and Riso, C. Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain Res. Bull. 55 (2001) 247-251.
• 4.Ito, Y., Niiya, Y., Kurita, H., Shima, S. and Sarai, S. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int. Arch.Occup. Environ. Health 56 (1985) 119-127.
• 5.El-Sokkary, G.H., Reiter, R.J., Cuzzocrea, S., Caputi, A.P., Hassanein, A.M.M. and Tan, D.X. Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in nonseptic shock induced by zymosan. Shock 12 (1999) 402-408.
• 6.El-Sokkary, G.H. Melatonin protects against oxidative stress induced by the kidney carcinogen KBr03. Neuroendocrinol. Lett. 21 (2000) 461-468.
• 7.Lee, Y.M., Chen, H.R., Hsiao, G., Sheu, J.R., Wang, J.J. and Yen, N.H. Protection effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J. Pineal Res. 33 (2002) 72-80.
• 8.Parlakpinar, H., Sahna, E., Ozer, M.K., Ozugurlu, F., Vardi, N. and Acet, A. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal toxicity. J. Pineal Res. 33 (2002) 161-167.
• 9.Reiter, R.J., Tan, D.X., Cabrera, J., D’Arpa, D., Sainz, R.M., Mayo, J.C. and Ramos, S. The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. 8 (1999) 56-63.
• 10.Tan, D.X., Reiter, R.J., Manchester, L.C., Yan, M.T., El-Sawi, M., Sainz, R.M., Mayo, J.C., Kohen, R., Allegra, M. and Hardeland, R. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Topics Med. Chem. 2 (2002) 181-192.
• 11.Allegra, M., Reiter, R.J., Tan, D.X., Gentile, C., Tesoriere, L., Livrea, M.A. The chemistry of melatonin’s interaction’s interaction with reactive species. J. Pineal Res. 34 (2003) 1-10.
• 12.Tan, D. X., Chen, 1. D., Poeggeler, B., Manchester, L. C., Reiter, R. J. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1 (1993) 57-60.
• 13.Zang L.Y., Cosma, G., Gardner, H. and Vallynathan, V. Scavenging of reactive oxygen species by melatonin. Biochem. Biophys. Acta 1452 (1998) 469-477.
• 14.Turjanski, A.G., Sanez, D.A., Doctorovich, F., Estrin, D.A. and Rosenstein, E. Nitrosation of melatonin by nitric oxide: A computational study. J. Pineal Res. 31 (2001) 97-101.
• 15.Blanchard, B., Pompon, D. and Ducroq, C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J. Pineal Res. 29 (2000) 184-192.
• 16.Tan, D.X., Manchester, L C., Reiter, R.J., Plummer, B.F., Limson, J.,Weintraub, S.T. and Qi, W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29 (2000) 1177-1185.
• 17.Reiter, R.J., Tan, D.X., Osuna, C. and Gitto, E. Actions of melatonin in the reduction of oxidative stress: a review. J. Biomed. Sci. 7 (2000) 444-448.
• 18.Garcia, J.J., Reiter, R.J., Ortiz, G.G., Oh, C.S., Tang, L., Yu, B.P. and Escames, G. Melatonin enhances tamoxifin’s ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation. J. Membr. Biol. 162 (1998) 59-65.
• 19.Acuna-Castroviejo, D., Martin, M., Macias, M., Escames, G., Loen, J., Khaldy, H. and Reiter, R.J. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res. 30 (2001) 65-74.
• 20.Misra, H.P. and Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chein. 247 (1972) 3170-3175.
• 21.Beutler, E., Duron, O. and Kelly, B.M. Improved method for the involved in lead determination of blood glutathione. J. Lab. Clin. Med. 61 (1963) 882-888.
• 22.Moore, M.R., McIntosh, M.J. and Bushnell, W.R. The neurotoxicity of lead. Neurotoxicology 7 (1986) 541-556.
• 23.Jett, D.A. and Guilarte, T.R. Developmental lead exposure alters N-methyl- D-aspartate and muscarinic receptors in the rat hippocampus: An autoradiographic study. Neurotoxicology 16 (1995) 7-18.
• 24.Stoltenburg-Didinger, G. Neuropathology of the hippocampus and its susceptibility to neurotoxic insult. Neurotoxicology 15 (1994) 445-450.
• 25.Nehru, B. and Sidhu, P. Behavior and neurotoxic consequences of lead on rat brain followed by recovery. Biol. Trace Elem. Res. 84 (2001) 113-121.
• 26.Hermes-Lima, M., Pereira, B. and Bechara, E.J.H. Are free radicals poisoning? Xenobiotica 21 (1991) 1085-1090.
• 27.Sandhir, R., Julka, D. and Gill, K.D. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol. Toxicol. 74 (1994) 66-71.
• 28.Jin, B.K., Shin, D.Y., Jeoing, M.Y., Gwag, M. R., Baik, H.W., Yoon, S.K., Cho, Y.H., Joo, W.S., Kim, Y.S. and Baik, H.H. Melatonin protects nigral dopaminergic neurons from l-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neurosci. Lett. 245 (1998) 61-64.
• 29. Tan, D.X., Manchester, L.C., Reiter, R.J., Qi, W., Kim, S.J., El-Sokkary, G.H. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. J. Neurosci. Res. 54 (1998) 282-289.
• 30. Lezoualc’h, F., Skutella, T., Widmann, M. and Behl, C. Melatonin prevents oxidative stress-induced cell death in hippocampal cells. NeuroReport 7 (1996) 2071-2077.
• 31. Skaper, S.D., Ancona, B., Facci, L., Franceschini, D. and Giusti, P. Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J. 12 (1998) 725-731.
• 32. Pappolla, M.A., Chyan, Y.J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J. and Reiter, R.J. An assessment of the antioxidant and antiamyloidogenic properties of melatonin: Implications for Alzheimer’s disease. J. Neurol Transm. 107 (2000) 203-231.
• 33. Benitez-King, G. and Anton-Tay, F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 49 (1993) 635-641.
• 34. Huerto-Delgadillo, L., Anton-Tay, F. and Benitez-King, G. Effects of melatonin in microtubule assembly dependent on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal Res. 17 (1994) 55- 62.
• 35. Floreani, M., Skaper, S.D., Facci, L., Lipartiti, M. and Giusti, P. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB J. 11 (1997) 1309-1315.
• 36. Mohan, N., Sadeghi, K., Reiter, R.J., Meltz and M.L. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kB. Biochem. Mol. Biol. Int. 37 (1995) 1063-1070.
• 37. Pozo, D.J., Reiter, R.J., Calvo, J.R. and Guerrero, J.M. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65 (1997) 430- 442.
• 38. Antolin, I., Rodriguez, C., Sainz, R.M., Mayo J.C., Uria, H., Kotler, M.L., Rodriguez-Colunga, M.J., Tolivia, D. and Menendez-Pelaez, A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10 (1996) 882-890.